Cargando…
Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL
Background: Recently, it was reported that leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4, also called GPR48) is another receptor for RANKL and was shown to compete with RANK to bind RANKL and suppress canonical RANK signaling during osteoclast differentiation. The critical role o...
Autores principales: | Jang, Yuria, Sohn, Hong Moon, Ko, Young Jong, Hyun, Hoon, Lim, Wonbong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795528/ https://www.ncbi.nlm.nih.gov/pubmed/33406741 http://dx.doi.org/10.3390/ijms22010434 |
Ejemplares similares
-
RANKL immunisation inhibits prostate cancer metastasis by modulating EMT through a RANKL-dependent pathway
por: Park, Mineon, et al.
Publicado: (2021) -
A novel modified RANKL variant can prevent osteoporosis by acting as a vaccine and an inhibitor
por: Ko, Young Jong, et al.
Publicado: (2021) -
TRPM7 Is Essential for RANKL-Induced Osteoclastogenesis
por: Yang, Yu-Mi, et al.
Publicado: (2013) -
Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis
por: Erkhembaatar, Munkhsoyol, et al.
Publicado: (2015) -
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
por: Kim, Jeong Yeon, et al.
Publicado: (2012)